At its core, this persistence of providentialism reveals a profound human impulse: the need for a unifying story to guide both individual lives and society’s trajectory. Even in a secular age, we seek ...

The increased potency observed in CTX112 through novel edits has also raised expectations for its potential efficacy in autoimmune diseases, particularly systemic lupus erythematosus (SLE). In the ...

The potential success of CTX112 in autoimmune diseases, particularly in systemic lupus erythematosus (SLE), represents a significant opportunity for CRISPR Therapeutics to expand its therapeutic ...

CRISPR Therapeutics had a negative net margin of 118.13% and a negative return on equity of 12.15%. On average, analysts expect CRISPR Therapeutics to post $-5 EPS for the current fiscal year and ...